Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13328930 | 0.87 | FAAH (0.37) | FAAHEPHX2GAAKMT2AALDH1A1 | |
| SCHEMBL7941387 | 0.78 | GAA (0.36) | GAAKMT2AALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL14495295 | 0.73 | GAA (0.33) | GAAALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL15681313 | 0.73 | GAA (0.41) | GAAL3MBTL1 | |
| SCHEMBL6392805 | 0.72 | HPGD (0.56) | GAAKMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL20537295 | 0.71 | ALOX5 (0.39) | GAAKMT2AALDH1A1MAPTL3MBTL1 | |
| SCHEMBL13636416 | 0.70 | HPGD (0.59) | GAAKMT2AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL6607606 | 0.70 | HPGD (0.59) | GAAKMT2AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL28533937 | 0.70 | LMNA (0.38) | KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL13979303 | 0.70 | GAA (0.39) | GAAKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718096-B2 | Stabilized electrochromic media | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-7678381-B2 | Stabilized body care products, household products, textiles and fabrics | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-03-16 | — | — | US | disclosed |
| US-20070079446-A1 | Stabilized body care products, household products, textiles and fabrics | CIBA SPECIALTY CHEMICALS CORP. | 2007-04-12 | — | — | US | disclosed |
| US-20070002423-A1 | Stabilized electrochromic media | CIBA SPECIALTY CHEMICALS CORP. | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070079446-A1 | Stabilized body care products, household products, textiles and fabrics | CUTA, NISCH, DSC1 | FAAH 167/4885EPHX2 1840/4885GAA 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.